Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
May 31, 2020
May 31, 2019
May 31, 2020
May 31, 2019
Income Statement [Abstract]        
Net revenue $ 22,264 $ 41,486 $ 87,369 $ 101,982
Cost of goods sold 19,892 34,090 86,634 86,834
Gross profit 2,372 7,396 735 15,148
Operating expenses:        
Selling, general and administrative 12,719 20,719 60,977 52,032
Gain on disposition of assets 0 0 0 (1,254)
Change in fair value of contingent consideration 0 2,961 0 (2,247)
Restructuring costs 952 0 8,253 0
Total operating expenses 13,671 23,680 69,230 48,531
Loss from operations (11,299) (16,284) (68,495) (33,383)
Other income (expense):        
Change in fair value of warrant liability (1,160) 6,254 3,435 7,309
Increase (Decrease) in Equity Securities, FV-NI (9) (71) (1,100) (663)
Interest expense (1,487) (474) (4,594) (1,452)
Other income (expense), net 468 (10) 386 110
Total other income (expense) (2,188) 5,699 (1,873) 5,304
Loss before income taxes (13,487) (10,585) (70,368) (28,079)
Income tax expense 0 (13) 0 (13)
Net loss $ (13,487) $ (10,598) $ (70,368) $ (28,092)
Net loss per share:        
Basic net loss per common share $ (0.11) $ (0.12) $ (0.64) $ (0.34)
Diluted net loss per common share $ (0.11) $ (0.19) $ (0.64) $ (0.42)
Weighted-average common shares outstanding        
Basic weighted average number of common shares outstanding 119,574 88,286 110,440 83,338
Diluted weighted average number of common shares outstanding 119,574 88,377 110,440 83,535